Effects of metformin on the gut microbiota: A systematic review

P Petakh, I Kamyshna, A Kamyshnyi - Molecular Metabolism, 2023 - Elsevier
Background The gut microbiota is increasingly recognized as a crucial factor in human
health and disease. Metformin, a commonly prescribed medication for type 2 diabetes, has …

Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis

M Buchynskyi, I Kamyshna, K Lyubomirskaya… - Frontiers in …, 2023 - frontiersin.org
Introduction IFN-α intervention may block SARS-CoV-2 replication and normalize the
deregulated innate immunity of COVID-19. Aim This meta-analysis aimed to investigate the …

[HTML][HTML] The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin

P Petakh, V Oksenych, A Kamyshnyi - Biomedicine & Pharmacotherapy, 2023 - Elsevier
The pandemic of COVID-19 has highlighted the intricate relationship between gut
microbiome and overall health. Recent studies have shown that the Firmicutes …

Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method

P Petakh, N Kobyliak, A Kamyshnyi - Frontiers in Cellular and Infection …, 2023 - frontiersin.org
Background The global pandemic of coronavirus disease 2019 (COVID-19) continues to
affect people around the world, with one of the most frequent comorbidities being Type 2 …

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis

M Buchynskyi, V Oksenych, I Kamyshna, SG Vari… - Viruses, 2023 - mdpi.com
Metabolic-associated fatty liver disease (MAFLD) and its potential impact on the severity of
COVID-19 have gained significant attention during the pandemic. This review aimed to …

Weil's Disease—Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota

P Petakh, V Isevych, A Kamyshnyi, V Oksenych - Biomolecules, 2022 - mdpi.com
Leptospirosis is an important zoonotic disease, causing about 60,000 deaths annually. In
this review, we have described in detail the immunopathogenesis of leptospirosis, the …

Do patients with and survivors of COVID-19 benefit from telerehabilitation? A meta-analysis of randomized controlled trials

J Huang, Y Fan, K Zhao, C Yang, Z Zhao… - Frontiers in Public …, 2022 - frontiersin.org
Background Coronavirus disease 2019 (COVID-19) significantly impacts physical,
psychological, and social functioning and reduces quality of life, which may persist for at …

Metformin therapy changes gut microbiota alpha-diversity in COVID-19 patients with type 2 diabetes: the role of SARS-CoV-2 variants and antibiotic treatment

P Petakh, I Kamyshna, V Oksenych, D Kainov… - Pharmaceuticals, 2023 - mdpi.com
The gut microbiota play a crucial role in maintaining host health and have a significant
impact on human health and disease. In this study, we investigated the alpha diversity of gut …

The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence

M Buchynskyi, I Kamyshna, V Oksenych, N Zavidniuk… - Viruses, 2023 - mdpi.com
The global population is currently experiencing the impact of the SARS-CoV-2 coronavirus,
which has caused the Coronavirus Disease 2019 (COVID-19) pandemic. With our profound …

[HTML][HTML] Effects of metformin, insulin on hematological parameters of COVID-19 patients with type 2 diabetes

P Petakh, V Griga, IB Mohammed, K Loshak… - Medical …, 2022 - ncbi.nlm.nih.gov
Background: COVID-19 infection caused by SARS-COV-2 can result in multi-organ injuries
and significant mortality in severe and critical patients, particularly those with type 2 diabetes …